In the SURPASS clinical trial program, post-hoc analyses revealed decreases in hsCRP levels among tirzepatide-treated participants compared to baseline
Epigenetic and Cellular Reprogramming: By blocking NNMT-mediated methylation of nicotinamide, preserves NAD salvage pathway activity, increases SIRT-1 signaling, reduces histone deacetylation, and promotes metabolic reprogramming toward oxidative phosphorylation and glycolysis balance, supporting tissue repair and energy homeostasis 1-4
Scarano A, Iezzi G, Petrone G, Orsini G, Degidi M, Strocchi R, et al
Step 4: Add Water to Peptide Vial Clean the rubber stopper of the AOD-9604 vial with an alcohol prep pad
200mcg/day The entry-level aod 9604 dosage
BPC-157 BPC-157 is a synthetic peptide derived from a naturally occurring protective protein sequence found in gastric juice